scispace - formally typeset
D

Dong-Sheng Huang

Publications -  21
Citations -  277

Dong-Sheng Huang is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 9 publications receiving 197 citations.

Papers
More filters
Journal ArticleDOI

Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.

TL;DR: A new avenue for TNBC treatment is opened by targeting the EZH2-H3K27me3-TET1 pathway that can modulate the epigenetic landscape and provide evidence regarding how to exploit it as a novel therapeutic target via its pivotal role in senescence and apoptosis control.
Journal ArticleDOI

HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.

TL;DR: The results showed that increased expression of HOXB7 might play an important role in promoting GC proliferation, migration and invasion by inducing both AKT and MAPK pathways, thus resulting in progression of, and poor prognosis in GC patients.
Journal ArticleDOI

Prevalence of deleterious ATM germline mutations in gastric cancer patients.

TL;DR: This study discovered two germline ATM mutations in a Chinese family with a history of gastric cancer by screening 83 cancer susceptibility genes and found deleterious germline mutations of ATM in 2.7% of 335 Gastric cancer patients of different ethnic origins.
Journal ArticleDOI

CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma

TL;DR: Data mining results show that CEACAM6 is overexpressed in gastric cancer and is correlated with lymph node metastasis, and data mining discovered that Tamoxifen etc. could be therapeutic alternatives for gastric patients with CEACam6 overexpression.